Larimar Therapeutics Announces the Dosing of the First Patient in Long-term Open Label Extension Study for Nomlabofusp in Patients with Friedreich’s Ataxia

3M ago

LRMR

More LRMR News >

LRMR News on the Web

2024-05-30

Buy Rating on Larimar Therapeutics: Navigating FDA Approval with Promising FA Treatment

TipRanks News

Bullish

2024-05-30

Larimar Therapeutics Selected by FDA to Participate in START Pilot Program for Nomlabofusp in Friedreich’s Ataxia

Yahoo Finance

Neutral

2024-05-24

The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics

Zacks

Neutral

2024-05-23

Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News

Zacks

Neutral

2024-05-22

Larimar (LRMR) Up on Lifting of Partial Clinical Hold on FA Study

Zacks

Bullish

2024-05-21

Larimar clinical hold lift 'very positive for the stock,' says Leerink

The Fly

Neutral

2024-05-21

Larimar clinical hold removal 'nice surprise,' says William Blair

The Fly

Neutral

2024-05-21

Health Care Sector Update for 05/21/2024: LRMR, AZN, LLY, XLV, IBB

MTNewswires

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is LRMR’s Media Buzz Sentiment?

Currently, no data Available

What is LRMR’s weekly average amount of articles?

Currently, no data Available

What is LRMR’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

2367Giant Biogene Holding Co. Ltd.

MXCTMaxCyte

VRDNViridian Therapeutics

ALURAllurion Technologies

MCKMcKesson

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing